Health Consultant Anant Agarwal in an episode of Figuring Out With Raj Shamani explains that circulating tumor cell (CTC) technology can detect cancer using as little as half a millilitre of plasma. He says some companies report accuracy levels as high as 99.6 percent in early-stage detection. Agarwal emphasizes that cancer outcomes depend heavily on early diagnosis rather than treatment alone.